MTNB (Matinas BioPharma Holdings) FCF Margin %: 0.00% (As of Mar. 2026)


MTNB Matinas BioPharma Holdings Inc MTNB
30 GF Score
Price $0.62
! 3 Warning Signs
View Full Analysis

What is Matinas BioPharma Holdings FCF Margin %?

Matinas BioPharma Holdings MTNB -4.18% 30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates MTNB with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Matinas BioPharma Holdings ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Matinas BioPharma Holdings's Free Cash Flow for the three months ended in Mar. 2026 was $-1.60 Mil. Matinas BioPharma Holdings's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Matinas BioPharma Holdings's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Matinas BioPharma Holdings's current FCF Yield % is -165.58%.

The historical rank and industry rank for Matinas BioPharma Holdings's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Matinas BioPharma Holdings was -628.86%. The lowest was -46918.18%. And the median was -9047.50%.

MTNB's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Matinas BioPharma Holdings FCF Margin % Related Terms

Matinas BioPharma Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for Matinas BioPharma Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Matinas BioPharma Holdings FCF Margin % Chart

Matinas BioPharma Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -46,918.18 -628.86 -1,413.87 0.00 0.00

Matinas BioPharma Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MTNB vs DRMA, MBIO, ADIL: FCF Margin % Comparison

For the Biotechnology subindustry, Matinas BioPharma Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Matinas BioPharma Holdings FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Matinas BioPharma Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Matinas BioPharma Holdings's FCF Margin % falls into.


MTNB
30GF Score
Matinas BioPharma Holdings Inc MTNB
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Matinas BioPharma Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Matinas BioPharma Holdings's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.011/0
= %

Matinas BioPharma Holdings's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.601/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Matinas BioPharma Holdings (MTNB) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Matinas BioPharma Holdings and its competitors. According to the industry distribution chart, Matinas BioPharma Holdings ranks #999999 out of 960 companies in the Biotechnology industry.
Is Matinas BioPharma Holdings' FCF Margin % too high?
Matinas BioPharma Holdings' current FCF Margin % is 0.00%. Based on the distribution chart, Matinas BioPharma Holdings ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Matinas BioPharma Holdings has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Matinas BioPharma Holdings' FCF Margin % compare to DRMA and MBIO?
According to the Biotechnology industry distribution chart, Matinas BioPharma Holdings ranks #999999 out of 960 companies for FCF Margin %. This places Matinas BioPharma Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Matinas BioPharma Holdings and its competitors. Matinas BioPharma Holdings's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Matinas BioPharma Holdings stock overvalued right now?
Matinas BioPharma Holdings (MTNB) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Matinas BioPharma Holdings' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Matinas BioPharma Holdings (MTNB), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Matinas BioPharma Holdings Business Description

Address 1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
30GF Score

Get the complete analysis for MTNB

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.62
Price